Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on: January 02,2024 10

Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on:January 02,2024 10

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on: January 04,2024 7

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on:January 04,2024 7

Study finds older cancer patients would benefit from geriatric assessment screening

by Rebecca Biason,University of TorontoEORTC QLQ C30 global health subscale QOL over time. Model predicted QOL stratified by curative versus palliative on the basis of our latent growth curve mo

Updated on: February 01,2024 18

Study finds older cancer patients would benefit from geriatric assessment screening

by Rebecca Biason,University of TorontoEORTC QLQ C30 global health subscale QOL over time. Model predicted QOL stratified by curative versus palliative on the basis of our latent growth curve mo

Updated on:February 01,2024 18

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were

Updated on: February 03,2024 14

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were

Updated on:February 03,2024 14

Blocking glycogen, a key energy source, could slow or prevent ovarian cancer spread

by University of Chicago Medical CenterPathways of early (proliferation) and late (proliferation, invasion and widespread) metastasis. Credit: Study authors working withCell MetabolismIn ne

Updated on: April 01,2024 11

Blocking glycogen, a key energy source, could slow or prevent ovarian cancer spread

by University of Chicago Medical CenterPathways of early (proliferation) and late (proliferation, invasion and widespread) metastasis. Credit: Study authors working withCell MetabolismIn ne

Updated on:April 01,2024 11

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Updated on: February 20,2024 20

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Updated on:February 20,2024 20

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i

Updated on: January 13,2024 16

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i

Updated on:January 13,2024 16

Unhealthy gut sets stage for breast cancer to spread, research reveals

byUniversity of VirginiaCredit: Unsplash/CC0 Public DomainAn unhealthy gut triggers changes in normal breast tissue that helps breast cancer spread to other parts of the body, new research from

Updated on: January 16,2024 19

Unhealthy gut sets stage for breast cancer to spread, research reveals

byUniversity of VirginiaCredit: Unsplash/CC0 Public DomainAn unhealthy gut triggers changes in normal breast tissue that helps breast cancer spread to other parts of the body, new research from

Updated on:January 16,2024 19

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024 14

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024 14

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024 18

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024 18

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on: January 22,2024 17

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on:January 22,2024 17

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Updated on: March 30,2024 12

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Updated on:March 30,2024 12